接受静脉-动脉体外膜氧合治疗的成人上消化道出血:一项队列研究
该回顾性队列研究纳入2014至2022年巴黎Bichat-Claude Bernard大学医院455例连续VA-ECMO患者,48例(10%)发生上消化道出血(UGIB)。UGIB患者死亡率75% vs 无UGIB患者60%,且ICU、ECMO和机械通气时间均更长;消化性溃疡病史、双联抗血小板治疗和体外心肺复苏与UGIB风险独立相关。
要点
- VA-ECMO成人患者中UGIB发生率为10%,中位发生时间为ECMO置管后12天。
- UGIB患者死亡率75%,无UGIB患者60%,且ICU、ECMO和机械通气时间更长。
- 消化性溃疡病史、双联抗血小板治疗和体外心肺复苏与UGIB风险独立相关。
核心结论
- 在VA-ECMO成人患者中,胃溃疡病史、双联抗血小板治疗和体外心肺复苏与UGIB风险增加独立相关。
- 本研究提示急性缺血-再灌注损伤可能在VA-ECMO相关UGIB的病理生理中发挥作用。
研究设计与样本
- 回顾性队列研究,纳入2014至2022年法国巴黎Bichat-Claude Bernard大学医院内科和感染病ICU连续接受VA-ECMO的成人患者,共455例。
- UGIB定义为呕血、黑便或便血等显性出血,或上消化道内镜诊断病变相关的急性贫血;VA-ECMO相关UGIB定义为VA-ECMO期间或撤机患者拔管后10天内发生的UGIB。
- 采用病因特异性模型分别识别与UGIB和死亡相关的因素。
主要发现
- 455例患者中48例(10%)诊断为UGIB,发生于ECMO置管后中位12[7; 23]天。
- UGIB患者死亡36例(75%),无UGIB患者死亡243例(60%)。
- UGIB患者较无UGIB患者ICU住院时间更长(32[19; 60]天 vs 18[7; 37]天;P < 0.01),ECMO时间更长(14[9; 18]天 vs 7[4; 11]天;P < 0.01),机械通气时间更长(21[16; 36]天 vs 10[5; 20]天;P < 0.01)。
- 共行90次上消化道内镜,最常见病变为胃十二指肠溃疡(n = 23,26%),并进行了11/90次治疗性操作。
- 多变量分析显示,消化性溃疡病史(病因特异性风险比CSHR 2.93,95%CI[1.01; 8.51])、双联抗血小板治疗(CSHR 2.0,95%CI[1.07; 3.72])和体外心肺复苏(CSHR 2.78,95%CI[1.42; 5.45])与UGIB风险增加独立相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Upper gastrointestinal bleeding (UGIB) is a common complication in adults treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic shock or cardiac arrest. We aimed to determine risk factors, prevalence and outcomes associated with VA-ECMO-associated UGIB in adult patients. METHODS: We conducted a retrospective cohort study (2014-2022) on consecutive VA-ECMO patients in the medical and infectious disease intensive care unit of Bichat-Claude Bernard University Hospital, Paris, France. UGIB was defined as (i) an overt bleeding (haematemesis, melena, haematochezia) or (ii) acute anaemia associated with a lesion diagnosed on upper gastrointestinal endoscopy. VA-ECMO-associated UGIB was defined as an UGIB occurring during VA-ECMO, or up to 10 days after decannulation in patients weaned off extracorporeal membrane oxygenation (ECMO). Cause-specific models were used to identify factors associated with UGIB and death, respectively. RESULTS: Among the 455 patients included, 48 (10%) were diagnosed with UGIB after a median of 12 [7; 23] days following ECMO cannulation. Mortality occurred in 36 (75%) patients with UGIB and 243 (60%) patients without. UGIB patients had longer intensive care unit stays (32 [19; 60] vs 18 [7; 37] days; P < 0.01), longer ECMO (14 [9; 18] vs 7 [4; 11] days; P < 0.01) and mechanical ventilation durations (21 [16; 36] vs 10 [5; 20] days; P < 0.01), as compared to non-UGIB patients. Ninety upper gastrointestinal endoscopies were performed, and the most frequent lesions detected were gastro-duodenal ulcers (n = 23, 26%), leading to 11/90 therapeutic procedures. By multivariable analysis, a history of peptic ulcer [cause-specific hazard ratio (CSHR) 2.93, 95% confidence interval (CI) [1.01; 8.51]], a dual antiplatelet therapy (CSHR 2.0, 95% CI [1.07; 3.72]) and extracorporeal cardiopulmonary resuscitation (CSHR 2.78, 95% CI [1.42; 5.45]) were independently associated with an increased risk of UGIB. CONCLUSIONS: In adult patients under VA-ECMO, a history of gastric ulcer, dual antiplatelet therapy and extracorporeal cardiopulmonary resuscitation were independently associated with an increased risk of UGIB. This study highlights the potential role of acute ischaemia-reperfusion injury in the pathophysiology of VA-ECMO-associated UGIB.
引用
- Stern J, Dupuis C, Kpeglo H, et al. Upper gastrointestinal bleeding in adults treated with veno-arterial extracorporeal membrane oxygenation: a cohort study. Eur J Cardiothorac Surg. 2023. PMID: 36916745. doi:10.1093/ejcts/ezad083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。